Pfizer CEO Bourla acquires 20 cash-settled stock units

The units are settled in cash following separation from service and may be transferred to an alternative investment account at any time.

Available on EDGAR 11/03/2026 - 09:05 AM EST Accepted by SEC EDGAR 11/03/2026 - 09:05 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Pfizer Inc. Chairman & CEO Albert Bourla acquired 20 Phantom Stock Units SSP on October 30, 2026, reported at $30.52 per unit. Each unit represents one phantom share of common stock; Bourla's reported direct position after the transaction was 783,828 units. The units were acquired under Pfizer Inc.'s Nonfunded Deferred Compensation and Supplemental Savings Plan and are settled in cash following his separation from service; he may transfer them to an alternative investment account at any time.

Insider Trade Summary

Grant/Award: 20 shares

Grant/Award 1 txn

Insider BOURLA ALBERT

Role Chairman & CEO

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units SSP F1, F2	20	$30.52	$610.40

Holdings After Transaction: Phantom Stock Units SSP — 783,828 contracts (Direct)

Holdings Before and After: Phantom Stock Units SSP, 783,808 to 783,828 contracts (Direct)

Footnotes (2)

1. F1. Each unit represents one phantom share of common stock.
2. F2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Key Figures

Phantom Stock Units SSP acquired: 20 units Reported price per unit: $30.52 per unit Direct Phantom Stock Units SSP after transaction: 783,828 units +1 more

4 metrics

Phantom Stock Units SSP acquired 20 units October 30, 2026

Reported price per unit $30.52 per unit October 30, 2026 transaction

Direct Phantom Stock Units SSP after transaction 783,828 units Reported following the October 30, 2026 transaction

Phantom shares represented by each unit 1 phantom share per unit Each unit represents one phantom share of common stock

Key Terms

Phantom Stock Units SSP, Nonfunded Deferred Compensation and Supplemental Savings Plan, separation from service

3 terms

Phantom Stock Units SSP financial

"20 Phantom Stock Units SSP"

Nonfunded Deferred Compensation and Supplemental Savings Plan financial

"acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan"

separation from service technical

"settled in cash following the reporting person's separation from service"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PFE phantom stock units did Albert Bourla acquire?

Albert Bourla acquired 20 Phantom Stock Units SSP on October 30, 2026, at a reported $30.52 per unit. His reported direct position after the transaction was 783,828 units.

How are Albert Bourla's PFE phantom units settled?

The units were acquired under Pfizer Inc.'s Nonfunded Deferred Compensation and Supplemental Savings Plan and are settled in cash following his separation from service. Bourla may transfer them into an alternative investment account at any time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOURLA ALBERT

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units SSP	(1)	10/30/2026		A		20		(2)	(2)	Common Stock	20	$30.52	783,828	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

	/s/ Shanice A. Reid, by power of atty., for Albert Bourla	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)